Azul Optics
Founded 2016 · 4 employees on LinkedIn · 1 known investors
Azulo Optics develops diagnostic devices that measure blue light damage to the retina, helping eye care practices screen patients for macular degeneration risk and boost revenue through preventive vision care services.
Also known as Azul Optics Ltd
Investors · 1
Company profile
researched Aug 2026Azul Optics develops the MP-eye, a screening device used in eye care practices to measure how well a patient's macula is protected against violet-blue light. The company positions the measurement as a way to identify patients with low blue-light defences, who may be at greater long-term risk of retinal damage and macular degeneration, and to inform conversations about protective products and behaviour.
The company presents the MP-eye as a complement to existing practice imaging such as OCT scans and fundus photography, with practitioners citing a patient-facing score that does not require clinician interpretation to be understood. Alongside the device, the company publishes educational material on the science of blue light and retinal damage, and on preventive measures patients can take through life.
Business model
The company sells the MP-eye device to optometry and eye care practices, offering demonstrations of the device as an entry point; it positions the screening as an addition to advanced eye examinations and as a driver of practice revenue, including through protective products practices sell to at-risk patients.
▸Full profile — market position, technology, go-to-market
Market position
Positioned as a screening addition to advanced eye examinations in optometry practices, focused on measuring macular protection against violet-blue light.
Practitioners describe the device's output as an easily understood patient-facing score, used as a focal point for patient education about macular health, unlike imaging outputs that require clinician interpretation.
Technology
The MP-eye measures a patient's macular defences against violet-blue light and outputs a score that patients can interpret directly, in contrast to OCT images or fundus photographs that require clinician interpretation.
Go-to-market
Direct outreach to eye care practices through bookable in-practice demonstrations of the MP-eye, supported by practitioner testimonials and educational content about blue light and retinal protection.
Optometrists, optical doctors and eye care clinics that offer advanced eye examinations and preventive vision care to their patients.
Compiled by commissioned research from 2 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 2
primary sources listed
- Azul Opticsazuloptics.com · web
2 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Azul Optics do?
- Azul Optics makes the MP-eye, a device that measures patients' macular defences against violet-blue light for eye care practices.
- Who are Azul Optics's investors?
- Azul Optics's investors include Parkwalk Advisors.